Literature DB >> 23823952

Diagnostic utility of endoscopic ultrasound guided aspiration cytology in evaluation of pancreatic masses.

Asim Qureshi1, Usman Hassan, Asif Loya, Noreen Akhter, Aasim Yusuf.   

Abstract

OBJECTIVE: To determine the sensitivity and specificity of endoscopic ultrasound (EUS) guided fine needle aspiration cytology (FNAC) in the evaluation of pancreatic masses. STUDY
DESIGN: Analytical study. PLACE AND DURATION OF STUDY: Department of Pathology, Shaukat Khanum Cancer Hospital and Research Centre, from January 2006 to June 2011.
METHODOLOGY: Patients of either gender aged above 18 years who underwent EUS guided FNAC of pancreatic masses detected on abdominal CT, were included in the study. Biphasic abdominal CT scans were carried out for all the patients, followed by EUS guided FNAC. All material aspirated for cytologic evaluation was assessed for sample adequacy on-site, followed by formal examination for diagnostic purposes.
RESULTS: The mean age of patients tested was 58.94 ± 12.84 years with age ranging from 23 to 78 years. Regarding gender 23/42 (54.76%) patients were male and 19/42 (45.24%) were female. Out of 42 cases, 27 (64%) cases were diagnosed as adenocarcinoma, 4 (9.5%) as benign, 4 (9.5%) as mucinous cystic neoplasm, 2 (4.7%) as chronic pancreatitis, 2 (4.7%) as non-diagnostic, 2 (4.7%) as atypical cells seen and 1 (2.38%) as non-Hodgkin's lymphoma. The results were in full concordance with radiologic findings.
CONCLUSION: EUS guided FNA is an excellent procedure for evaluation of pancreatic masses. The overall sensitivity of this procedure is 89% and the specificity is 67%.

Entities:  

Mesh:

Year:  2013        PMID: 23823952     DOI: 07.2013/JCPSP.484486

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  5 in total

Review 1.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

2.  ZIP4 is a novel diagnostic and prognostic marker in human pancreatic cancer: a systemic comparison between EUS-FNA and surgical specimens.

Authors:  C Xu; M B Wallace; J Yang; L Jiang; Q Zhai; Y Zhang; C Hong; Y Chen; T S Frank; J A Stauffer; H J Asbun; M Raimondo; T A Woodward; Z Li; S Guha; L Zheng; M Li
Journal:  Curr Mol Med       Date:  2014-03       Impact factor: 2.222

3.  Initial Experience of Utilizing Real-Time Intra-Procedural PET/CT Biopsy.

Authors:  Carina Mari Aparici; Rizwan Aslam; Aung Zaw Win
Journal:  J Clin Imaging Sci       Date:  2014-09-29

4.  Endoscopic ultrasound pin-points the precision medicine for pancreatic cancer.

Authors:  Ping Zhu; Siyu Sun
Journal:  Endosc Ultrasound       Date:  2016 Jan-Feb       Impact factor: 5.628

5.  Clinical predictors of resectability of pancreatic adenocarcinoma.

Authors:  Majid A Almadi; Othman Alharbi; Nahla Azzam; Mohannad Altayeb; Moammed Javed; Faisal Alsaif; Mazen Hassanain; Abdulsalam Alsharabi; Khalid Al-Saleh; Abdulrahman M Aljebreen
Journal:  Saudi J Gastroenterol       Date:  2013 Nov-Dec       Impact factor: 2.485

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.